Watch replays of the main stage programming from the SOSV Climate Tech Summit (Nov. 5-6)

Changing the way we treat ADHD

GET CONNECTED
neurode.com.au

Team

Nathalie Gouailhardou

CEO & Co-Founder

Damian Sofrevski

Co-Founder

Neurode

Company details

Neurode is developing an at home wearable device for ADHD therapy. Their solution monitors brain activity and pairs with an app to provide a therapy for ADHD, eliminating the need for pharmaceuticals.

Female FoundersHuman HealthAustraliaSeedDigital HealthHealthcareHuman HealthMental HealthHAX 2021

Company News

Can at-home brain stimulators make you feel better? – The Economist

April 25, 2025
The Economist

Some startups and investors are more risk-averse than others – TechCrunch

September 14, 2024
TechCrunch

Neurode wants to treat and track ADHD symptoms through a wearable headband

September 12, 2024
TechCrunch

Australian scientists drive neurotech research, ahead of Neuralink – Interesting Engineering

March 19, 2024
Interesting Engineering

Get In Touch with Neurode

Please tell us a little bit about yourself and why you'd like to get connected. Neurode + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More